The antipsychotic drug, Risperdal, may result in excessive male breast growth, especially when taken by young boys. This condition, known as gynecomastia, can result in pain and embarrassment for its victims, and often requires extensive surgery to remove excess breast tissue.
Bernstein Liebhard LLP provides legal assistance to men and boys who may have experienced the growth of female like breasts due to their use of Risperdal. If you or someone you love were diagnosed with gynecomastia while using this medication, please contact our Firm by calling (888) 994-5118.
Risperdal was initially approved by the U.S. Food & Drug Administration (FDA) for the treatment of schizophrenia in adults. In 1969, Johnson & Johnson and Janssen Pharmaceuticals sought to have the drug approved for certain pediatric indications, but the FDA declined due to lack of evidence regarding its safety. In 2006 and 2007, Risperdal’s approved uses were expanded to include the treatment of bipolar disorder in adults and children, schizophrenia in children, and certain behavioral symptoms in children with autism.
Risperdal (risperidone) works by blocking the activity of dopamine in certain areas of the brain, which in turn impacts the pituitary gland. Among other things, the pituitary gland is responsible for the production of prolactin, a hormone which plays a role in female breast development and lactation. In recent years, research has accumulated that links Risperdal to excessive levels of prolactin and the development of gynecomastia in boys and men.
Gynecomastia is a condition in which men or boys develop female-like breast. The excess breast tissue is not related to weight gain, and will not go away even if the individual loses weight. In addition to the growth of mammary tissue, those suffering from gynecomastia might experience:
Gynecomastia will not go away on its own, even once a patient stops taking Risperdal. Mild cases of male breast growth may resolve with liposuction. But more serious cases will require extensive surgery, up to and including mastectomy. Once the tissue has been removed, reconstructive surgery of the skin may be needed.
The pain and emotional trauma suffered by victims of gynecomastia is very real. If male breast growth is the result of Risperdal, victims may be entitled to compensation from Johnson & Johnson and Janssen. A successful lawsuit could provide financial damages to cover:
Hundreds of Risperdal lawsuits have been filed in U.S. courts on behalf of gynecomastia victims. This includes more than 1,600 cases that are currently pending in a mass tort program underway in the Pennsylvania Court of Common Pleas in Philadelphia. That litigation convened several male breast growth trials in 2015, three of which resulted in substantial verdicts for plaintiffs. Read More
If you or a loved one experienced male breast growth that could be associated with Risperdal, now is the time to learn more about your possible legal options. To do so, please call (888) 994-5118 to contact an attorney at Bernstein Liebhard LLP.
Get the latest news and litigation updates about this case by following us on Facebook. Click the "Like" button below.